To define, describe, and forecast the global digital PCR (dPCR) and real-time/quantitative PCR (qPCR) market on the basis of technology, product and service, application, end user, region
- Agency -.
The global digital PCR and real-time PCR (qPCR) market is estimated to grow at a CAGR of 8.9% from 2017 to 2022 to reach USD 5.31 Billion by 2022.
Get Sample Copy [email protected] www.rnrmarketresearch.com/contacts…le?rname=1096838
The key factors driving the growth of this market include growth in the geriatric population, rising incidence of infectious diseases and genetic disorders, increasing investments and availability of funds for PCR-based research, and increasing use of biomarker profiling for disease diagnosis. However, factors such as high cost of dPCR products and technical limitations associated with qPCR and dPCR are restraining the growth of this market.
“The dPCR technology segment to grow at faster pace than qPCR technology segment during the forecast period.”
Based on the type of technology, the dPCR and qPCR market is classified into digital PCR (dPCR) and quantitative PCR (qPCR).
- Agency -.
However, the dPCR technology segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the ongoing technological developments in dPCR, significant adoption of dPCR products among target end users, expansion of distribution networks of emerging dPCR product manufacturers, and growing private funding for the development and commercialization of innovative dPCR instruments.
Report on Digital PCR and Real-time PCR (qPCR) Market 2017-2022 spreads across 215 pages profiling 15 companies and supported with 89 tables and 63 figures available at www.rnrmarketresearch.com/contacts…nt?rname=1096838
*Top 13 Companies Analysed for This Study are - Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd.
(Switzerland), Bio-Rad Laboratories, Inc. (U.S.), Qiagen N.V. (Netherlands), Takara Bio, Inc.
(Japan), Agilent Technologies, Inc. (U.S.), Biomérieux S.A. (France), Fluidigm Corporation (U.S.), Danaher Corporation (U.S.), ABBott Laboratories (U.S.), Merck KGaA (Germany), Promega Corporation (U.S.), Becton, Dickinson and Company (U.S.), Meridian Bioscience, Inc. (U.S.), Analytik Jena AG (Germany), Eppendorf AG (Germany), Bioneer Corporation (South Korea), Enzo Life Science, Inc. (U.S.), Quanta Biosciences Inc. (U.S.), Elitech Group (France), Formulatrix, Inc. (U.S.), Jn Medsys (Singapore), Denville Scientific Inc. (U.S.), Biomeme Inc. (U.S.), and Biosystemika, Research and Development LLC (Slovenia),
- qPCR and dPCR Product Manufacturing Companies
- Healthcare Service Providers (including Hospitals and Diagnostic Centers)
- Research and Development (R&D) Companies
- Pharmaceutical and Biotechnology Companies
- Research Laboratories and Academic Institutes
- Clinical Research Organizations (CROs)
- Forensic Laboratories
- Market Research and Consulting Firms
- Government and Independent Regulatory Authorities
Key point from table of content
7 Global qPCR and dPCR Market, By Technology
7.2 Quantitative PCR (qPCR)
8 Global qPCR and dPCR Market, By Product and Service
8.2 qPCR Products and Services
8.2.1 qPCR Reagents and Consumables
9 qPCR and dPCR Market, By Application
9.2 qPCR Applications
9.2.1 Clinical Applications
10 qPCR and dPCR Market, By End User
10.2 Quantitative PCR (qPCR) End Users
10.2.1 Hospitals and Diagnostic Centers
Browse Here for full Report with TOC: www.rnrmarketresearch.com/digital-…arket-report.html
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
For more information: